Press Releases

Date	Title	Company
19-Dec-2023	Biosynth to Offer Complex Chemistry Solutions at Greater Scales Following Acquisition of VIO Chemicals	Biosynth
19-Dec-2023	Philip Morris International Announces Senior Global Communications Leadership Changes	Businesswire
19-Dec-2023	New hot-flush treatment VEOZA▼™ (fezolinetant): first-in-class non-hormonal medicine for moderate to severe vasomotor symptoms associated with menopause licensed in Great Britain	Astellas Pharma Inc
19-Dec-2023	Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction	Achilles Therapeutics
19-Dec-2023	Shionogi announces agreement with SOBI on Fetcroja®▼ (cefiderocol) to expand access for patients with infections due to aerobic Gram-negative organisms in adults with limited treatment options.	Shionogi B.V.
19-Dec-2023	Santhera’s AGAMREE (Vamorolone) Approved in the European Union for the Treatment of Duchenne Muscular Dystrophy	Santhera Pharmaceuticals
19-Dec-2023	Recipharm Harmonises its Global Quality Operations with Veeva Vault Quality	Veeva Systems
19-Dec-2023	HERVOLUTION Therapeutics Appoints Biotech Builder J. Robert Coleman as CEO to Accelerate Groundbreaking Immunotherapies to Treat Dark Genome Targets in Cancer, Aging, and Neurodegeneration	HERVOLUTION Therapeutics
19-Dec-2023	Shorla Oncology & EVERSANA Announce U.S. Commercial Launch of FDA-Approved JYLAMVO, the First and Only Oral Methotrexate Solution Approved in the U.S. for Adults	Shorla Oncology
19-Dec-2023	Aldeyra Therapeutics Announces Statistically and Clinically Significant Improvement from Baseline in Phase 2 Clinical Trial of ADX‑629 in Patients with Atopic Dermatitis	Businesswire
19-Dec-2023	MAIA Biotechnology Announces Dose Selection in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer	Businesswire
19-Dec-2023	FDA Grants Priority Review to Merck’s New Biologics License Application for V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed to Protect Adults	Businesswire
19-Dec-2023	CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE	AccessWire
19-Dec-2023	CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE	CureVac
19-Dec-2023	Manure Scoring Clearly Established as Qualitative Scientific Measurement	AccessWire
19-Dec-2023	Recipharm harmonizes its global quality operations with Veeva Vault Quality	Recipharm
19-Dec-2023	Get Well Announces Expansion Into Health Plans, Brings Health Plan Strategy Expert Christian Bagge to Lead Go-to-Market Efforts	AccessWire
19-Dec-2023	NanOlogy Clinical and Preclinical Immune Data Presented at NACLC and SITC	Businesswire
19-Dec-2023	AscellaHealth Identifies Key Health Trends for 2024: Forecasts Robust Outlook for Specialty Pharmacy Industry	Businesswire
19-Dec-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire